Health Care

Chart of the Day: How Taxes and Transfers Affect US Incomes

By Michael Rainey

A new analysis of the distribution of household income by the Congressional Budget Office shows how taxes and means-tested transfers such as Medicaid and food stamps affect US incomes. “The combined...
The $65 Billion Superbug Threat to the US

By Yuval Rosenberg

Antibiotic-resistant superbugs are a deadly and expensive health threat — one that could largely be addressed for just a couple of dollars per person a year, according to an OECD report released this...
What the Exit Polls Revealed on Taxes and Health Care

By The Fiscal Times Staff

Here's what exit polls told us about some key issues: 45 percent: NBC News’ exit poll found that 45 percent of voters said the Republican tax cuts had no impact on their personal finances, compared...
Fiscal Mayhem Ahead in 2019 — and 5 Other Takes on the Election Results

By The Fiscal Times Staff

Prepare for budget mayhem: “The budget bottom line is simple: Senate Republicans will have a very different fiscal agenda than House Democrats, and both houses’ tax and spending to-do lists will be...
What Should Democrats Do Now That They’ve Won the House?

By Michael Rainey

With Democrats winning control of the House Tuesday, political experts are lining up to give advice on what they should do with their new powers. While there’s little chance of enacting significant...

3 Areas Where Trump and Democrats Can Maybe, Possibly Work Together

By Yuval Rosenberg

Will divided government lead to anything beyond more legislative gridlock? President Trump and Democratic leader Nancy Pelosi, the presumptive next speaker of the House, have both spoken...
3 Election Takeaways on Health Care

By Yuval Rosenberg

Midterm voters made it clear that health care issues mattered to them, even if it proved less than decisive in the outcome of some major races. A plurality of voters, 41 percent , told exit pollsters...
A Life-Saving Drug Could Come with a $4 Million Price Tag

By Yuval Rosenberg

Swiss drugmaker Novartis hinted Monday that it is considering charging an eye-popping price as high as $4 million to $5 million for a life-saving new gene therapy to cure rare cases of a disease...
Chart of the Day: Who Voters Trust with Medicare

By Yuval Rosenberg

Older Americans come out to vote — and they trust Democrats more than Republicans on health care, writes Drew Altman of the Kaiser Family Foundation at Axios . Advantage Democrats, right? Maybe, but...
$Senator Bernie Sanders (I-VT) speaks during an event to introduce the "Medicare for All Act of 2017\$

What’s The Difference Between Medicare-For-All and Single-Payer?

By Samantha Young, Kaiser Health News

MODESTO, Calif. — Betsy Foster and Doug Dillon are devotees of Josh Harder. The Democratic upstart is attempting to topple Republican House incumbent Jeff Denham in this conflicted, semi-rural...

GOP’s Latest Campaign Punch on Health Care Relies on Classic Hook: Medicare

By Julie Rovner, Kaiser Health News

Once again, Medicare is front and center in this fall’s campaigns. Democrats throughout the election season have been hammering Republicans over votes and lawsuits that would eliminate insurance...
Transfer Payments Hit $3 Trillion Annual Pace

By The Fiscal Times Staff

Total government transfers reached $3 trillion on an annualized basis for the first time in September, according to data released by the Bureau of Economic Analysis Monday. Transfer payments include...
Paid Family Leave: The Leading Democratic and Republican Proposals, Explained

By Emily Zeppieri, The Fiscal Times

Since 1993, the Family and Medical Leave Act (FMLA) has provided workers with the right to unpaid time off and guaranteed job security following qualified medical and family events, including...
Americans Are Spending More on Health Care Out of Their Own Pockets

By The Fiscal Times Staff

Americans are spending more and more on out-of-pocket health-care costs. A report released this week by the JPMorgan Chase Institute finds that annual growth in out-of-pocket spending has accelerated...
Why Trump’s Medicare Plan Won’t Cut Prices Anytime Soon

By Yuval Rosenberg

President Trump’s newly unveiled test plan to lower Medicare Part B drug costs may have limited resonance in the days before the midterm elections — and could face a difficult, if not impossible,...